OverviewThe Ipamorelin and CJC-1295 (No DAC) combination is examined in research models studying growth hormone–related signaling pathways. Research FocusResearchers use this peptide pairing to evaluate GHRH receptor activity, ghrelin-related signaling, and synergistic receptor interactions. Mechanism of InterestThe combination allows investigation of multi-pathway GH-axis signaling, contributing to studies of peptide structure–function relationships. Compliance NoticeFor research only. Not for human consumption.